Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent (DECLARELONG)

This study has been completed.
Sponsor:
Collaborator:
Otsuka Korea
Information provided by:
CardioVascular Research Foundation, Korea
ClinicalTrials.gov Identifier:
NCT00589927
First received: December 31, 2007
Last updated: March 17, 2010
Last verified: July 2009